SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Guilford (GLFD) - Steadily Rising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BRAVEHEART who wrote (302)5/27/1999 2:28:00 PM
From: BRAVEHEART  Read Replies (1) of 496
 
Hi Marty,

I learned today that GLFD is unaware of who is responsible for the block transactions. Waiting on the public filings.

GLFD is anticipating a response from Europe for product approval in nine Europeian countries over the next few weeks. Also GLFD is due approximately 7.5 million in milestone payments upon pricing approval. GLFD's product is cheaper than systemic cancer treatments so I cannot see this being much of an issue.

Also AMGN has stated publicly that it is going to be filing for a targeted indication this year. I don't think they would mention this if it wasn't some time relatively soon. Any guesses. Parkensons?This should lead to upgrades.

Which should get the ball rolling... : )

Jeffrey
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext